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Abstract: Background: There is a need for tools that provide prediction of peri-implant disease.
The purpose of this study was to validate a risk score for peri-implant disease and to assess
the influence of the recall regimen in disease incidence based on a five-year retrospective cohort.
Methods: Three hundred and fifty-three patients with 1238 implants were observed. A risk score
was calculated from eight predictors and risk groups were established. Relative risk (RR) was
estimated using logistic regression, and the c-statistic was calculated. The effect/impact of the
recall regimen (≤ six months; > six months) on the incidence of peri-implant disease was evaluated
for a subset of cases and matched controls. The RR and the proportional attributable risk (PAR)
were estimated. Results: At baseline, patients fell into the following risk profiles: low-risk (n = 102,
28.9%), moderate-risk (n = 68, 19.3%), high-risk (n = 77, 21.8%), and very high-risk (n = 106, 30%).
The incidence of peri-implant disease over five years was 24.1% (n = 85 patients). The RR for the risk
groups was 5.52 (c-statistic = 0.858). The RR for a longer recall regimen was 1.06, corresponding to a
PAR of 5.87%. Conclusions: The risk score for estimating peri-implant disease was validated and
showed very good performance. Maintenance appointments of < six months or > six months did not
influence the incidence of peri-implant disease when considering the matching of cases and controls
by risk profile.
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1. Introduction
Peri-implant disease is considered a pathological condition occurring in tissues around dental
implants, characterized by inflammation in the peri-implant connective tissue and progressive loss
of supporting bone [1,2]. The weighted mean prevalence (95% confidence interval) of peri-implant
disease is estimated to be 19.83% (15.38, 24.27) at the patient level and 9.25% (7.57, 10.93) at the implant
level [3].
Recently, a large case-control study was conducted that examined several risk factors for
peri-implant disease: history of periodontitis, bone level, lack of passive fit or non-optimal screw joint,
bacterial plaque, bleeding, type of material used in the restoration, proximity of other implants/teeth
and current smoking [4]. The same study estimated a potential risk score for predicting peri-implant
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disease. However, the risk score was not validated in a different cohort than that from where the data
were originally collected.
Profiling patients according to their risk for a disease is currently a priority in public health
research, with significant efforts being made to introduce prevention and treatment strategies that
account for individual variability [5]. In other medical specialties, profiling a patient’s individual risk
for a particular health-related outcome through a risk score has been previously reported, such as the
prediction of serious bleeding after primary percutaneous coronary interventions [6], risk scores for
predicting adverse reaction to contrast agents for computed tomography [7], or estimation of coronary
heart disease risk [8].
In Dentistry, one prevention strategy in both Periodontal and Implant Dentistry is the
recall regimen, accounting for patients’ signs and symptoms along with patient compliance and
acceptance. Recall regimens are designed to help predict the long-term success of an outcome [9–13].
Specifically, a recall interval of five to six months has been proposed as the minimum required for
successful outcomes in implant dentistry [12–14]. The strength of this recommendation is based on a
“D” classification—the lowest classification based on extrapolation from other categories of evidence,
evidence from expert committee reports or opinions, clinical experience of respected authorities, or a
combination of these categories [14]. Consequently, more research is necessary to produce evidence for
recommending recall regimens.
The primary aim of this study was to validate a risk score for peri-implant disease. The secondary
aim of this study was to investigate the influence of recall regimens on the incidence of
peri-implant disease.
2. Materials and Methods
2.1. Study Design, Study Population, Ethics, Inclusion and Exclusion Criteria
This retrospective cohort study was approved by the Ethical Committee for Health (authorization
010/2013), the Faculty of Medicine, University of Lisbon Ethical Board (Process 270/2015), and the
Faculty of Medicine-University of Lisbon Scientific Board (Process CC-120), and follows the Helsinki
Declaration of 1975, as revised in 2000. The patients provided their informed consent to participate in
the study. The study was conducted at a private rehabilitation center (Lisbon, Portugal) concerning
patient rehabilitation and follow-up and at the Faculty of Medicine, University of Lisbon, between
March 2015 and August 2017 (data collection, analysis and interpretation).
The study population consisted of male and female patients over 18 years of age who received
a fixed prosthesis supported by dental implants at a private practice (Lisbon, Portugal) between
January and December 2006. The inclusion criterion was patients with rehabilitated dental implants
with at least 5 years of follow-up after the insertion of the rehabilitation, healthy or with a systemic
condition and irrespective of the smoking status. Exclusion criteria were patients not followed by our
team and patients with implants that failed (early complete implant failures during osseointegration,
during the first year of follow-up) [15] or had unresolved biological complications (abscess, infection,
or fistulae) during the first year of follow-up whose signs and symptoms could overlap with the
clinical manifestations of peri-implant disease.
A total of 504 surgery records referring to 479 patients with 1676 implants were reviewed
corresponding to the total number of patients rehabilitated between January and December of 2006
at the private practice. Sixty patients with a total of 206 implants were excluded for the following
reasons: 43 patients (126 implants) were not followed by our team; 12 patients (60 implants) presented
unresolved biological complications during the first year of follow-up; five patients (11 implants)
had failures during the first year of follow-up (in addition to 7 implants from two of these patients
who were considered survivals but were still not included in the analysis). Additionally, 12 patients
(22 implants) had two different surgical interventions for implant rehabilitation in the same year,
but with more than 6 months between them. For these patients, only the implants from the first
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surgical intervention were included in this analysis. Sixty-six patients (18.7%) with 210 implants
(17.0%) were lost to follow-up.
2.2. Sample Size
The final sample included a total of 353 patients (211 female, 142 male) with an average
age of 52.5 years (standard deviation: 11.75 years; age range: 18 to 87 years) and 1238 implants
(Brånemark system, NobelSpeedy, Nobel Biocare AB, Göteborg, Sweden). The sample size allowed for
the detection of a true relative risk of 1.74 in exposed subjects relative to unexposed subjects, assuming
the probability of exposure among controls of 21% [16] with 80% power and a type I error probability of
5% (power and sample size calculations, version 3.0.34, Dupont WD and Plummer WD Jr, Department
of Biostatistics, Vanderbilt University, Nashville, TN, USA).
2.3. Outcome Measures, Variables
The primary outcome measure was the model’s discrimination capacity for predicting
peri-implant disease. Peri-implant disease (dependent variable) was defined as the presence of
peri-implant pockets ≥5 mm, bleeding upon probing, the concurrent presence of vertical bone loss
visible in the periapical radiograph compared to the previous evaluation and/or attachment loss
≥2 mm compared to the previous evaluation [4]. The current risk score derived from the construction
of a model referred to in a previous publication [16]. In brief, the following steps were taken in the
construction of the model: First, a univariable statistical evaluation was performed between potential
risk factors and peri-implant disease. The following variables were evaluated considering the potential
association with peri-implant disease:
Classification of comorbidities according the American Society of Anesthesiology (ASA)
(ASA I-III); history of head and neck irradiation <6 months; history of chemotherapy <6 months;
smoking habits (non-smoker, smoker); history of periodontitis (periodontitis previous to the implant
rehabilitation or tooth loss due to periodontitis); postmenopausal hormone replacement therapy;
Implant location (mandible, maxilla), Implant position within the jaw (anterior, posterior); implant
orientation (axial, tilted), proximity of the implant to teeth or other implants (absence, presence of a
natural tooth or implant immediately next to the implant); implant length (7, 8.5, 10, 11.5, 13, 15 or
18 mm); implant diameter (3.3–3.5 mm, 3.75–4.3 mm, 5–6 mm); implant surface (machined, oxidized);
cantilevers (absence, 1 or more); implant-crown ratio (2:1, 1:1); type of abutment (straight, angulated
17 degrees, angulated 30 degrees); abutment height (1–5 mm); type of prosthetic restoration
(single tooth, fixed partial restoration or fixed total restoration); type of material used in the restoration
(ceramic, metal–ceramic, metal–acrylic, acrylic); fracture of prosthetic components within the previous
year of diagnosis, lack of prosthetic fit or non-optimal screw joint (defined as the loosening of prosthetic
screw or the visible gap between prosthetic components); implants in grafted bone; implants inserted
in post-extraction sockets; implants inserted in periodontally compromised sites; phasing of implant
restoration (2-stage: implant insertion in a first surgery, followed by a healing period between
4–6 months, and a second surgery for abutment connection; 1-stage: implant and abutment insertion
on the same surgery; immediate function: implant, abutment and connection of the restoration on
the same day of surgery); presence of bacterial plaque, presence of bleeding, bone level (located on
the implants’ coronal, or medium thirds); time in months between clinical evaluation appointments.
The variables individually associated with the incidence of peri-implant disease were tested in a
multivariable conditional logistic regression model. The variables were introduced following a criterion
of biological plausibility (first) and statistical performance (second). The statistical performance was
evaluated according to the variables’ statistical significance (p < 0.05) and the models’ goodness of fit
(Likelihood ratio test). The exceptions were the variables “bacterial plaque” and “smoking habits” that
were always included in the model given their potential confounder effect, and this way, the effect of
confounding variables was considered to have been reduced by multivariable analysis. Interaction
between variables was performed based on biological plausibility and previous scientific reports
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(bacterial plaque and proximity of the implant to other teeth or implants). The final model was
derived and β coefficients were used to transform the risk model in the current risk score. The risk
score was tested for external validation in a different population of patients in the present study.
Considering the risk score, the predictor variables (collected at baseline) were history of Periodontitis
(present or absent), bone level (located on the implants’ coronal third or implants’ middle third), lack of
a passive fit or a non-optimal screw joint (presence or absence of prosthetic passive fit, prosthetic screw
loosening, abutment screw loosening, prosthetic decementations), bacterial plaque (modified plaque
index [17] and recorded as presence or absence), bleeding (modified bleeding index [17] and recorded
as presence or absence), type of material used in the restoration (ceramic, metal–ceramic, metal–acrylic,
acrylic resin), proximity of other implants/teeth (presence or absence) and current smoking status.
Baseline measurements were taken one-year post-surgery. This time point was chosen to prevent
overlap between early implant failures and peri-implant disease. A risk score was calculated from
the sum of the scores for each predictor to estimate the likelihood of peri-implant disease, shown in
Table 1. Risk groups were established using the total score for each patient and separating them into
four categories of risk for peri-implant disease: low risk, moderate risk, high risk, and very high risk
(Table 1).
Table 1. Baseline patient characteristics, risk score points and illustration of the relationship between
the points system and the risk profile groups.
Variable Total (n = 353)n (%)
Risk Score
Points *
History of Periodontitis 137 (38.8) 5
Bone level located on the implants’ middle third 20 (5.7) 5
Lack of prosthetic fit or non-optimal screw joint (passive misfit abutment
screw loosening, prosthetic screw loosening, prosthetic decementations) 20 (5.7) 3
Bacterial plaque 187 (53) 2
Bleeding 175 (49.6) 2
Type of material used in the restoration
Ceramic 79 (22.4) 0
Metal–ceramic 186 (52.7) 2
Metal–acrylic 104 (29.5) −2
Acrylic 42 (11.9) 1
Adjacent implants or teeth present 214 (60.6) −1
Simultaneous presence of bacterial plaque and adjacent
implants or teeth present 90 (25.5) 3
Smoker 83 (23.5) 0
Risk profile groups obtained from the sum of risk score points for each variable
Risk profile Low risk Moderate risk High risk Very high risk
Number of points <2 points 2–4 points 5–7 points >7 points
* De Araújo Nobre et al. 2016 [4].
The secondary outcome measure was the effect of the average time interval between maintenance
appointments (≤6 months or >6 months) during follow-up on the incidence of peri-implant disease.
This was evaluated for a subset of cases and matched controls using a nested case-control study design.
Cases were defined as patients with peri-implant disease; controls were defined as patients without
peri-implant disease during the 5-year follow-up. Sampling was performed by including all cases
and randomly sampling controls matched for risk category for peri-implant disease (the high- and
very high-risk groups were combined in order to sample from the controls). The average time
interval between maintenance appointments was calculated by dividing the time between the
surgery date and the diagnosis of peri-implant disease by the number of maintenance appointments
in that period (for cases) or by dividing the total time of follow-up (60 months) by the number
of maintenance appointments in that period (for controls). The average time interval between
maintenance appointments was recoded into a dichotomous variable (≤6 months or >6 months).
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2.4. Statistical Analyses
Descriptive statistics included means and standard deviations to describe quantitative variables
and frequencies to describe qualitative variables. The prevalence of peri-implant disease was calculated.
Inferential analysis was performed as follows. Relative risk (RR) for peri-implant disease for each
“risk groups” was calculated using logistic regression. Receiver operating characteristic (ROC) curves
were calculated along with their 95% confidence intervals (95% CI). The risk group discrimination was
computed using c-statistics (95% CI).
The effect that maintenance appointments with time intervals of >6 months had on the incidence
of peri-implant disease was evaluated for a subset of cases and matched controls using conditional
logistic regression for estimation of RR with 95% CI. The impact that 6-month or greater time intervals
between maintenance appointments had on the incidence of peri-implant disease was estimated as the
attributable risk percent (ARP) using the RR: ARP = (RR − 1) / RR [18]. The significance level was
set at 5%. Statistics were performed using Statistical Package for Social Sciences (SPSS, version 17.0,
IBM SPSS, New York, NY, USA).
3. Results
3.1. Primary Outcome Measure: Model Discrimination Capacity
The distribution of patients across risk groups was 102 patients with low risk (28.9%), 68 patients
with moderate risk (19.3%), 77 patients with high risk (21.8%), and 106 patients with very high
risk (30%) (Table 2). The incidence of peri-implant disease in the cohort was 24.1% (n = 85 patients).
The distribution of peri-implant disease according to the groups of risk was two patients with moderate
risk (2.9%), 22 patients with high risk (28.6%), and 61 patients with very high risk (57.5%).














Demographics N (within group %) N (within group %) N (within group %) N (within group %)
Average age in years 49.5 52.7 53.5 54.6
Sex
Female 56 (54.9%) 50 (73.5%) 45 (58.4%) 60 (56.6%)
Male 46 (45.1%) 18 (26.5%) 32 (41.6%) 46 (43.4%)
Predictors N (within group %) N (within group %) N (within group %) N (within group %)
History of Periodontitis 0 (0%) 13 (19.1%) 43 (55.8%) 81 (76.4%)
Bone level located on the implants’
middle third 0 (0%) 0 (0%) 2 (2.6%) 18 (17%)
Lack of prosthetic fit or non-optimal
screw joint 0 (0%) 2 (2.9%) 2 (2.6%) 16 (15.1%)
Bacterial plaque 6 (5.9%) 37 (54.4%) 49 (63.6%) 95 (89.6%)
Bleeding 11 (10.8%) 35 (51.5%) 42 (54.5%) 87 (82.1%)
Type of restoration material
Ceramic 39 (38.2%) 13 (19.1%) 15 (19.5%) 12 (11.3%)
Metal–ceramic 45 (44.1%) 26 (38.2%) 39 (50.7%) 76 (71.7%)
Metal–acrylic 22 (21.6%) 35 (51.5%) 29 (37.7%) 18 (17%)
Acrylic 6 (5.9%) 4 (5.9%) 9 (11.7%) 23 (21.7%)
Adjacent implants/teeth present 84 (82.4%) 26 (38.2%) 41 (53.2%) 63 (59.4%)
Interaction presence of bacterial plaque *
adjacent implants/teeth present 0 (0%) 9 (13.2%) 25 (32.5%) 56 (52.8%)
Smoker 19 (18.6%) 12 (17.6%) 22 (28.6%) 30 (28.3%)
“Risk group” was a significant risk factor in the logistic regression model with an RR = 5.52,
(95% CI: 3.64, 8.35) and a high degree of significance (p < 0.001 for the goodness of fit) (Table 3).
The model accuracy was 80.5%, with a sensitivity of 71.8% (61/85), and a specificity of 83.2% (223/268).
The area under the curve (95% confidence interval) was 0.858 (0.820, 0.896) (p < 0.001, c-statistic)
(Figure 1).
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95% Confidence Interval for RR
Lower Upper
Risk Group 1.71 0.212 p < 0.001 5.52 3.64 8.35
Constant −6.41 0.753 p < 0.001 0.002
R-square = 0.46; Omnibus test: p < 0.001; Hosmer and Lemeshow test: p = 0.139). Model evaluation parameters:
sensitivity, 71.8%; specificity, 83.2%; accuracy, 80.5%.
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Figure 1. Receiver operating characteristic curve illustrating the performance of the risk algorithm
(Area under the curve = 0.858, 95% confidence interval [0.820, 0.896], standard error = 0.019, p < 0.001,
cut-off point = 0.14).
Risk scores are presented in Figures 2 and 3. These scores can be used to obtain predictions
for individual patients. As an example, we will examine a 59 year-old female with no history of
periodontitis who was a non-smoker and who was rehabilitated with a three-unit implant-supported
rehabilitation (three implants of 7 mm in length, positions #44–#46) that were restored using
metal–ceramic material. At baseline (one year of follow-up) bacterial plaque and bleeding were
present, and the bone level was located on the implants’ coronal third (Figure 2), which produces a
total score of 8 points and puts her in the very high-risk profile. Peri-implant disease was diagnosed
after 58 months on implant #45 due to the presence of peri-implant pockets of 5 mm and a three thread
marginal bone loss (Figure 3).
3.2. Secondary Outcome Measure: Effect and Impact of Having > Six Months Intervals between
Maintenance Visits
The sub-sample included 85 cases (with peri-implant disease) and 85 controls
(without peri-implant disease), matched by risk group. The distribution of the predictor variable
(average interval between maintenance appointments) was as follows: 62 cases and 64 controls had
intervals between maintenance appointments of ≤ six months (incidence in the non-exposed = 0.49)
while 23 cases and 21 controls had intervals between maintenance appointments > six months
(incidence in the exposed = 0.52). The conditional logistic regression model did not show a significant
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effect of the time interval between maintenance appointments when comparing the two group, with a
RR = 1.13, (95% CI: 0.57, 2.21) (Table 4). The impact on the incidence of peri-implant disease assessed
through the attributable risk percent was 5.89%.J. Clin. Med. 2019, 8, x FOR PEER REVIEW 7 of 12 
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Figure 2. Baseline periapical radiograph (at one year of follow-up) from a 59 years old female
patient with no history of periodontitis who was a non-smoker, rehabilitated with a three-unit
implant-supported rehabilitation [three implants of 7 mm in length, positions #44–#46; Risk points = −1
due to adjacent implants or teeth present) restored using metal–ceramic material (Risk points = 2).
Bacterial plaque (Risk points = 2) and bleeding (Risk point = 2) were present, and the bone level was
located on the implants’ coronal third. Due to the presence of bacterial plaque and the presence of
adjacent implants or teeth, 3 risk points were added. A total score of 8 points was registered for this
patient which corresponded to the very high-risk group.
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>6 months between
maintenance appointme ts 0.118 0.344 p = 0.732 1.13 0.57 2.21
4. Discussio
The current study validated a risk score obtained from a model in a different population of patients,
with a high degree of significance (p < 0.001 for the goodness of fit) as well as an excellent discriminating
ability (c-statistic = 0.858) for indicating which implant-supported rehabilitation patients had a greater
risk for peri-implant disease during a five-year post-surgery follow-up period. This interpretation of
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the c-statistic result is supported by a previous publication that suggested that ROC curves falling on
the diagonal will approach the following c-statistic values for discrimination capacity: 0.5 when there
is no discriminating capacity to diagnose patients; 0.7–0.8 when there is acceptable discrimination;
0.8–0.9 when there is excellent discrimination capacity; and 0.9 or greater when there is outstanding
discrimination [19]. This risk score thus represents a valid tool for aiding clinicians in evaluating
a patient’s risk for peri-implant disease and providing important information at an early stage of
follow-up with the objective of avoiding the condition. The prevalence of peri-implant disease has
been reported across a broad range between 1% and 47% at the implant level, a variation that can
be attributed to differences in the terminology, etiology, and diagnostic criteria of the condition [12].
The currently used terminology of “peri-implantitis” has been challenged previously but is a term
for the use of unknown implant–host interfaces with a relatively good knowledge of the tooth–host
interface (periodontitis) [20]. This condition was assumed for the current investigations [4,16]. The use
of this definition is supported by recent genetic investigations that have revealed differences in
gene expression between patients with peri-implant disease and those with periodontitis [21,22].
The etiology, which is considered to be a pathology largely produced by a bacterial infection of
plaque accumulation [23], was previously refuted [4,16,23–27] after several factors aside from bacterial
plaque emerged as potential risk factors in a multivariable analysis [16,23]. Aside from the risk model
from which the present risk scores were derived [16], Konstantinidis et al. [25] also conducted a
cross-sectional study of 168 patients with 597 implants to evaluate the prevalence of and possible risk
indicators for peri-implant diseases. The study reported no association between high plaque scores
and peri-implant disease. Other theories include bone loss that is a result of a combination of factors
such as poorly manufactured implants, placement by untrained clinicians, and individual patient
characteristics [27]. Alternatively, the condition could be a result of an immunologically derived
rejection mechanism. In this theory, infection is considered to be a secondary event following a
disturbance in the immune system due to a foreign-body, such as the dental implant. The foreign
implant would then lead to immunological and inflammatory responses [28]. Additionally, different
causal models have been proposed that do not include bacterial plaque as a component cause [4,26],
such as the Sander Greenland component causal model [29]. This model states chronic diseases
are generally multifactorial and thus more than one causal mechanism may induce the condition,
with each causal mechanism being a product of the impacts of several component causes (risk factors).
Moreover, the diagnostic criteria for the condition’s clinical manifestation also differ across studies,
which makes it difficult to compare them [12]. Several risk factors included in the current validated
risk score were retrieved from a risk model [16] and were previously highlighted as risk indicators in
other studies using multivariable analysis. Not surprisingly, a history of periodontitis, bleeding, or
bacterial plaque [25,30–32] are all biological risk indicators and are supported by a greater amount
of research. However, other factors related to biomechanical aspects such as the presence of wear
facets on the prosthetic crown were found to be significantly associated with peri-implant disease [32].
Gurgel et al. [31] conducted a cross-sectional study with 155 patients to evaluate the frequency of
peri-implant diseases and factors associated with its occurrence. The study found that medication
use, the existence of two or more implants, and a gingival bleeding index >10% were risk indicators
for peri-implant disease when adjusted for other variables of interest. In a subsequent cross-sectional
analysis, Konstatinidis et al. [25] evaluated the potential risk indicators for peri-implant disease
using multi-level logistic regression models that registered both tooth loss due to periodontitis and
implants in the maxilla as risk indicators. Dalago et al. [32] also conducted a cross-sectional study with
183 patients and 916 implants that aimed to identify systemic and local risk indicators associated with
peri-implant disease. The study found significant associations between history of periodontal disease
(odds ratio = 2.2), cemented restorations (odds ratio = 3.6), total rehabilitations (odds ratio = 16.1),
and the presence of wear facets (odds ratio = 2.4). In contrast, Marrone et al. [30] found that in a
study with 103 patients with 266 implants, there were no significant effects for peri-implant disease
at the patient level using an age >65 years, total edentulism, hepatitis, active periodontitis, dental
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plaque ≥30%, Diabetes, history of Periodontitis, smoking, and dental visits ≤1 per year as explanatory
variables. The authors attributed these results to having a lower statistical power relative to the high
number of variables in the model.
Previous authors have addressed the importance of refining treatment plans through the use of
informed decision-making processes to improve the outcomes of implant-supported fixed prostheses.
Controlling risk factors and anticipating outcomes are an essential part of implant dentistry risk
management to prevent implant failure [33,34]. Moreover, controlling for risk would produce health
gains for patients and reduce time spent in a dental chair to resolve any mechanical complications
experienced [35].
The non-significant effect of the time interval between maintenance appointments on the incidence
of peri-implant disease in the present study agree with the results of previous systematic reviews.
Bidra et al. [14] conducted a systematic review to evaluate the evidence on patient recall and the
maintenance of implant-supported restorations. The review concluded that there was minimal
evidence related to recall regimens in patients with implant-supported restorations. This result inferred
a “D” classification (the lowest classification) regarding the level of evidence and the qualitative reserve
of not considering the recommendation as a standard of care [14]. Furthermore, Monje et al. [12]
identified a significant effect of peri-implant maintenance therapy on the incidence of peri-implant
disease, stressing the need to tailor the recall regimen to the patients’ risk profile and not to rely
on the interval between maintenance appointments alone. The modest impact of the recall regimen
registered in the present study (an increase of less than 6%) on the excess risk for peri-implant disease
is corroborated by the finding of Monje et al. [12] and underlines the potential greater importance
of each patients’ risk profile. A recent comment also highlighted this idea, stating that even when
maintenance therapy is provided, biological complications can still occur and that maintenance
therapy should be tailored to a patients’ risk profile [13]. For the avoidance of doubt, the result of
the present study should not be interpreted as labeling the recall regimen irrelevant to the outcome.
Rather, this study is suggesting that recall regimen is one piece of a more comprehensive approach to
preventing peri-implant disease. A previous systematic review highlighted the paramount importance
of individually tailored supportive programs that are based on patient motivation and re-instruction
in oral hygiene measures and combined with professional implant cleaning to prevent peri-implant
disease [11].
Given the implications that the validation of the risk score in the present study have for clinical
practice, the authors propose a comprehensive approach to managing patient risk. This approach
involves the measurement and management of, and communication about, risk. Measuring risk
involves assessing the risk factors for peri-implant disease and using a risk score and risk profile for
each patient. Managing risk is related to examining the implications of a patient’s risk profile result
and the deciding the necessary action(s) that should be taken. This decision should consider the use of
professional cleaning procedures, the maintenance instructions, patient motivation, the recall interval,
or changes in the prosthetic complex. Communicating risk involves sharing information about the risk
score with the patients, holding the patients responsible for their own health, and working together
on short term goals (one recall schedule at a time) that can improve the results of the risk assessment
(not only plaque control improvement but also smoking cessation and/or other lifestyle factors for
example). Ultimately, this could improve the result of the risk profile and recall regimen, via a positive
feedback mechanism. The rules necessary to apply the current risk score for prediction consist in
patients rehabilitated with dental implants, with at least one year of follow-up and with the possibility
of evaluating the patient’s periodontal history, clinical, and radiographic diagnosis. The risk score can
be performed in any evaluation appointment from the one year of follow-up onwards, enabling the
patient and clinician to work on the negative aspects present at that time.
The main strength of this study is that to the authors’ best knowledge, it presents the first risk score
for predicting peri-implant disease that has been validated for patients who were rehabilitated with
implant-supported restorations. Moreover, the predictive risk score had excellent discriminating ability,
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which will enable precise predictions. The limitations of this study included the study conduction
in a single center and one implant system (suggesting caution in extrapolating the results); the
fact that all variables were collected at baseline and their effect accounted for prediction in the
remaining of the follow-up irrespective of the status remaining unaltered or altering (for example:
plaque control; a limitation in every prediction study); and the average time between maintenance
appointments (as they could be unevenly distributed during the follow-up period) that was performed
for standardization and analytical purposes. The multifactorial origin of peri-implant disease presents
a challenge with direct implications in prediction across different populations as different variables
may exert an effect on the risk of incidence, making it impossible to account in a single model and
therefore posing a limitation of this study (such as different implant systems, implant micro and macro
designs, prosthodontic options, or even clinician experience). Despite being validated in a different
sample, studies of the different heterogeneous populations are needed to further strengthen the models’
external validity.
5. Conclusions
Within the limitations of this retrospective study it can be concluded that a tool that enables the
five-year prediction of peri-implant disease in patients with dental implants was validated. This tool
could be used in implant dentistry to improve the prognosis for implant-supported restorations,
providing a base for identifying patients at greater risk of peri-implant disease and enabling a stricter
control. Maintenance appointments of < six months or > six months did not influence the incidence of
peri-implant disease when considering the matching of cases and controls by risk profile.
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